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The ability of contrast-enhanced echocardiography to
localize and quantity myocardial infarction was studied
in 16 open chest dogs. Both routine and contrast-en-
hanced two-dimensional echocardiograms were re-
corded at baseline and 4 hours after occlusion of the left
anterior descending (n = II) or circumflex (n = 5)
coronary artery. Ultrasound contrast was produced by
injection into the aortic root of 3 ml of 0.3% hydrogen
peroxide mixed with 6 ml blood. Systolic wall thickening
was also measured and quantified as a marker of myo-
cardial infarction. Dogs were sacrificed after 4 hours of
coronary occlusion. The slice of the left ventricle that
corresponded to the two-dimensional echocardiogram
was stained with nitro-blue tetrazolium to localize the
infarct. The size of the myocardial infarct was deter-
mined by planlmetry,
The oxygen bubbles produced by mixing hydrogen
peroxide with blood produced an excellent intramyo-
cardial ultrasound contrast effect. Complete data were
available in 12 dogs. Contrast echocardiography accu-
The location and size of a myocardial infarct is a critical
factor in assessing prognosis in patients who sustain a myo-
cardial infarction. This assessment is currently made with
electrocardiography ( I), quantitative serum enzyme deter-
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rately localized the infarction in all 11 dogs with an
infarct documented by nitro -blue tetrazolium. The area
of the infarct, determined by planimetry and expressed
as a fraction of total myocardial area from the nitro-
blue tetrazolium study, correlated well with the size of
the infarct determined with contrast echocardiography
(correlation coefficient [r) = 0.92, standard error of the
estimate [SEE) = 0.05, probability [p) < 0.001). Intra-
and interob server correlations were excellent for the de-
termin ation of fraction of infarcted myocardium by con-
trast echocardiography (r = 0.93, P < 0.001, SEE =
0.04; r =0.89, p < 0.001, SEE = 0.07, respectively).
Absence of systolic wall thickening also accurately lo-
calized myocardial infarction, but correlated poorly with
the extent of infarction (r = 0.29, P = not significant).
It is concluded that contrast-enhanced two-dimen-
sional echocardiography, using a combination of hydro-
gen peroxide and blood to provide ultrasound contrast,
accura tely and reproducibly localizes and quantifies
myocardial infarction.
minations (2) and. more recently, radionuclide techniques
(3). Tw o-di men sional echocardiography has an advantage
over these techniques, in that in addition to the location,
both the anatomic and functional extent of an infarction
potentially can be determined. Routine two-dimensional
echocardiography. however, relies on either endocardial
motion or systolic wall thickening abnormalities as indi-
cators of myocardial ischemia or infarction. Endocardial
motion abnormalities overestimate infarct size (4,5) . Ab-
sence of normal systolic thickening may be a more accurate
marker of myocardial infarction. but is seen in areas of
subendocardial infarction (6) and has been shown to over-
estimate and correlate poorly with infarct size In acute in-
farction models (7).
We recently demonstrated that contrast-enhanced two-
dimensional echocardiography can localize nonperfused
myocardium after total coronary occlusion in a canine model
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of ischemi a (8). The technique was further validated by
Sakamaki et al. (9) , who used an agitated Renografin and
saline solution to produce ultra sound contrast. They reported
excellent agreement between results of contrast echocardi-
ography and monastral blue dye delineation of nonperfused
myocardium. Gaffney et al. (10) recently demonstrated that
clinicall y useful ultrasound contrast is produced by oxygen
bubbles formed in a mixture of hydrogen peroxide and blood.
The purpo ses of the current study were to assess the
ability of a hydrogen peroxide and blood mixture to serve
as an ultrasound contrast age nt suitable for visualization of
myocardial perfusion abnormalities, and to evaluate this
technique for the local ization and quantification of myo-
cardial infarction in a can ine model. A third aim of this
study was to compare contrast-enhanced echocardiography
and systolic wall thickening as markers for myocardial
infarction.
Methods
Experimental preparation. Experiments were per-
formed in 16 mongrel dogs weighing 18 to 26 kg , anesthe-
tized with sodium pentobarbital , maint ained with chloralose
anesthesia and ventilated with a Harvard veterinary respi-
rator. The heart was exposed through a right thorocotomy
and the pericardium opened. The left anterior descend ing
(n = II ) or circumflex coronary artery (n = 5) was isolated ,
and a snare was placed for later occlusion of the coronary
artery. Variable occlusion sites were used to provide a range
of infarct sizes.
The electrocardiogram and arterial blood pressure were
monitored continuously . A 7 Fren ch straight aortic catheter
with one end-hole and four side-holes was advanced from
a femoral artery into the aortic root. Its position was con-
firmed by palp ation and echocardiographic visualization.
Echocardiographic examination. All echocardiograms
were recorded using commercially available mechanical wide
angle scanners (Advanced Technology Laboratorie s, Inc).
In all studies, a 5 MHz transducer was placed directl y on
the free wall of the right ventricle; an acoustic stand off
was not utilized . Gain settings were opt imized to provide
the best image at the time of the initial examination and
were left unchanged throughout the experiment.
A stand ard 3% solution of hydrogen perox ide was diluted
with heparinized 0.9% saline solution to a concentration of
0 .3%, and 3 ml of this diluted solution was mixed with 6
ml of the dog ' s blood in a 10 ml syringe. This mixture was
then injected as a bolus into the aort ic root to produce an
ultrasound contrast effect.
Experimental protocol. A baseline two-dimensional
echocardiogram was recorded at or below the level of the
papillary muscles . A contrast injection was then performed
during continuous recording of the echoca rdiogram, and
afterward , the coronary artery was occluded. Routine and
contrast-enhan ced two-dimensional echoca rdiogram were
repeated at intervals of 30 to 60 minutes during the exper-
iment. After 4 hours of occlusion, the echocardiographic
transducer was fixed in position to provide the optimal
image of the area of infarction, and final routine and con-
trast-enhanced echocardiograms were recorded. Needles were
then passed through the heart in the plane of the echocar-
diograph ic examination to mark the slice of the left ventricle
for infarct anal ysis. After induction of deep surgical anes-
thesi a, the heart was removed , flushed with tap water and
sliced in a breadloaf fashion.
Nitro-blue tetrazolium studies. The I em slice of the
left ventricle that corresponded to the echocardiographic
examination was incubated with nitro-blue tetrazolium to
mark the area of the infarct (II). The anatomic spec imen
was photographed on 35 mm slide film. The photograph ic
image of the heart was then projected , and areas of infarcted
and noninfarcted tissue were outlin ed. The outlin es of the
images were digitized and the area of infarcted myocardium
and total myocardial areas were determined . The frac tion
of infarcted myocardium was calculated as the area of in-
farcted myocardium divided by the total myocardial area .
The fraction of infarcted myocardium was calculated only
for the slice of myocardium correspondin g to the echocar-
diographic exa mination. No attempt was made to determine
total infarct mass or fraction of the infarcted left ventricle .
Echocardiographic data. The echocardiog rams were
reviewed , and appropriate frames at basel ine and after 4
hours of coro nary artery occlusion, eac h with and without
contrast enhancement , were analyzed. Echocardiograms were
reviewed on a commercially available off-line system equipped
with a video disc (Micro Sonics) that permits presentation
of a stable, flicker-fr ee image for analysis. The cont rast-
enhanced frames that showed the best visual contrast effect
were chosen . The endocardial and epicardial outlines were
digitized and the areas bounded by the epica rdial and en-
docardi al contours were determined. Papillary muscles were
included in the endocardial outline . The area of the left
ventricular myocardium was calculated as the difference
between these two areas. The contour of the noncontrast-
enhanced left ventricular myocardium was then outl ined and
its area determined. The fraction of nonperfused left ven-
tricular myocardium was calculated as the area of noncon-
trast-enhanced myocardium divided by the total myocardial
area. A single echocardiog raphic plane of examination was
utilized for these calc ulations, and no attempt was made to
reconstruct the three-dimensional geometry of the infarc ted
myocardium or to calculate total myocardial infarction mass
or fraction of the whole left ventricle infarcted . This deter-
mination was performed by one observer on two separate
occasions and by another independent observer.
Wall motion studies. Systolic wall thickening was ana-
lyzed on the previously mentioned off-line system . The
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endocardial and epicardial contours at end-diastole and end-
systole were digitized. Papillary muscles were excluded from
the endocardial contour when a clear delineation between
the left ventricular myocardium and papillary muscle was
visible. For each image, 32 radians were generated from
the center of mass of each pair of systolic-diastolic contours.
Radians were aligned with reference to a preselected point
on the epicardial side of the echocardiographic image. Di-
astolic and systolic waIl thicknesses along each of 32 radians
were computed by the microprocessor computer of the off-
line system. Fractional systolic wall thickening was cal-
culated as (systolic wall thickness minus diastolic wall thick-
ness) divided by diastolic waIl thickness. Abnormal systolic
thickening was defined as a fractional systolic thickening
less than zero. The fraction of abnormal myocardium was
then calculated as the number of radians with abnormal
systolic wall thickening divided by 32.
Data analysis. For all calculations, the mean of three
measurements was used. Contrast echocardiographic and
nitro-blue tetrazolium data were compared by a standard
correlation coefficient and their relation described by linear
regression. Inter- and intraobserver correlations were also
determined using a standard correlation coefficient. Data
are presented as mean ± I standard deviation.
Results
Complete data were available in 12 of the 16 dogs. No
data were available in two dogs that had ventricular fibril-
lation early in the course of coronary occlusion. In two other
dogs that survived, contrast echocardiograms were obtained:
but, there was a loss of the nitro-blue tetrazolium data be-
cause of technical errors.
Infarct size determined by nitro-blue tetrazolium.
Myocardial infarction was present in II of 12 dogs, as
detected by staining with nitro-blue tetrazolium. The frac-
tion of infarcted myocardium determined by nitro-blue tet-
razolium was 0.07 to 0.55 (mean 0.23 ± 0.14 ). The infarct.
as defined by nitro-blue tetrazolium, was partiaIly nontrans-
mural in six dogs. Six infarcts involved a papillary muscle.
There was either no papillary muscle involvement or a purely
transmural infarction present in only two dogs.
Infarct size determined by contrast echocardiography.
At baseline, all areas of the left ventricular myocardium
increased in image intensity after injection of the hydrogen
peroxide-blood mixture (Fig. 1). The contrast effect had a
duration of 30 to 180 seconds. Contrast echocardiography
revealed distinct areas of the left ventricular myocardium
that failed to increase in image intensity after contrast en-
hancement in II dogs . The area of noncontrast-enhanced
myocardium corresponded to the anatomic infarct location
as defined by the nitro-blue tetralzolium study in each of
these II dogs (Fig. 2 to 4). In one dog. the contrast-en-
hanced echocardiogram was normal after 4 hours of coro-
nary occlusion, and no identifiable infarct was present after
staining with nitro-blue tetrazolium . Data from this dog were
excluded from further analysis.
Fraction of infarcted myocardium with contrast echo-
cardiography versus nitro-blue tetrazolium. The fraction
of infarcted myocardium as determined with hydrogen per-
oxide contrast echocardiography was 0.\2 to 0.48 (mean
0.23 ± 0.23). Correlation between results of contrast echo-
cardiography and infarct extent by nitro-blue tetrazolium
staining was excellent (correlation coefficient [r] = 0.92,
probability [pJ < 0.001. standard error of the estimate [SEE]
= 0.05) (Fig. 5). The relation of the fraction of infarcted
myocardium by the nitro-blue tetrazolium (NBT) and con-
trast echocardiographic (CE) data was best described by the
equation: CE = 0.73 NBT + 0.06 . The line described by
this equation is significantly different from the line of iden-
tity. Intra- and interobserver correlations for determination
Figure 1. Short-axis two-dimensionalechocardiogramat the level
of the papillary muscles before (A)and after (B)contrast enhance-
ment. Ultrasound image intensity increases in all areas of the
myocardium after injection of the hydrogen peroxide-blood mix-
ture into the aortic root.
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of the extent of infarcted myocardium by contrast echo-
cardiography were also excellent (r = 0.93, P < 0.001,
SEE = 0.04; r = 0.89, P < 0.001, SEE = 0.07 ,
respectively).
Systolic wall thickening. Systolic wall thickening was
calculated for all II dogs. The fraction of myocardium with
abnormal systolic thickening was 0.15 to 0.44 (mean 0.30
== 0.07). An area of abnormal systolic thickening corre-
sponded to the area of infarct determined by nitro-blue tet-
razolium in each dog. In four dogs. an area of systolic wall
thinning remote from the area of infarct was also seen.
Correlation between the fraction of myocardium showing
abnormal systolic thickening and results of the nitro-blue
tetrazolium analysis was poor (r = 0.29, P = not significant).
Figure 2. Same dog. Short-axis two-dimensional echocardro-
grams recorded after 4 hours of circumflex coronary artery occlu-
sion. PanelA is beforeandpanelB after injectionof the ultrasound
contrast agent. In panel B, all areas of the myocardium have
increased in image intensity with the exceptionof the myoca rdium
between 2 o'clock and 4 o'clock (black arrows). This corre-
sponded to the area of infarction determined with nitro-blue tet-
razolium (Fig. 3A). The fraction of infarcted myocardium deter-
mined by contrast echocardiography was 0.15; by nitro-blue
tetrazolium. 0.14; and by analysis of wall thickening, 0.26.
Blood pressure response. The rapid injection into the
aortic root of a 9 ml bolus of blood mixed with hydrogen
peroxide consistently produced a very brief increase in sys-
tolic and diastolic arterial pressures. followed by transient
hypotension that lasted 10 to 120 seconds. The decrease in
systolic blood pressure was 0 to 32 mm Hg (mean 7.5 ±
3.4). Mean arterial pressure transiently decreased a to 25
mm Hg (mean 8.8 == 3.4).
Electrophysiologic effects. Analysis of the electrocar-
diogram during and immediately after injection of the con-
trast material revealed transient bradycardia in two dogs and
an occasional premature ventricular contraction in another
two dogs. No effects were noted on the ST segment or T
wave after injection.
Discussion
In earlier studies (8), we demonstrated that new ultra-
sound contrast agents provide an intramyocardial contrast
effect that parallels myocardial perfusion as assessed with
radioactive microspheres. In this study. contrast-enhanced
echocardiography, using a combination of hydrogen per-
oxide and blood. accurately localized an established myo-
cardial infarction. The fraction of infarction determined by
contrast echocardiography correlated well with histologic
myocardial infarct size. Furthermore. analysis of systolic
wall thickening was not as accurate as contrast echocardi-
ography as a quantifiable marker of myocardial infarction.
Hydrogen peroxide as a contrast agent for echocardi-
ography: side effects and toxicity. Hydrogen peroxide is
an unstable compound, which when mixed with blood, is
acted on by peroxidase and catalase enzyme systems. This
chemical reaction releases oxygen at the molecular level
according to this equation: 2H202~ 2HP+02 (12). We
hypothesize that the oxygen thus generated forms micro-
bubbles coated with intrinsic plasma constituents. These
microbubbles are the source of the ultrasound contrast effect
(13). Gaffney et a!' (10) recently demonstrated excellent
right heart ultrasound contrast in human subjects after pe-
ripheral venous injection of a mixture of hydrogen peroxide
and blood. After multiple injections in volunteers and pa-
tients. they noted no adverse effects. Furthermore. hydrogen
peroxide has been utilized previously as an intraarterial agent
for treatment of atherosclerotic vascular disease and as an
adjunct in cancer therapy (14).
Gross et a!' (15) recently reported their experience with
intracoronary injections of hydrogen peroxide in a canine
model. They noted a dose-response effect for both produc-
tion of ultrasound contrast and complications. They also
reported a significant incidence of complications, including
ventricular fibrillation. with higher doses of hydrogen per-
oxide injected directly into the coronary arteries. Their model
differs from ours in that hydrogen peroxide was injected
JACC Vol. 2. No 1
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Figure 3. A, Photograph of the corresponding anatomic shce of
the left ventricle from the animal studied in Figures I and 2. The
dark areas of myocardium are normal; the pale yellow area is
the area of myocardial infarction. This area correspondsin location
to the area of nonperfused myocardiumnoted on the contrast echo-
graphic study (Fig. 2B). B, Anatomic specimen corresponding to
the echocardiogramin Figure 4. The dark areas representnormal,
noninfarcted myocardium; the pale areas represent the area of
myocardial infarction. This area of infarcted myocardium corre-
sponds to the area of myocardium in the echocardiogram that is
not contrast-enhanced (FIg. 4B). RV = fight ventricle.
directly into the coronary artery without prior mixing with
blood. In this model, the reaction that releases oxygen Will
take place not in vitro, but rather within the lumen of the
coronary artery. The effects of such an injection may be
substantially different from those of injection of a previously
mixed combination of blood and hydrogen peroxide. Al-
though we noted no substantial adverse effects on the car-
diovascular system from our injections, no attempt was made
to evaluate the effect of the oxygen bubbles or the hydrogen
peroxide and blood mixture on other vascular beds, such as
the central nervous system, renal or mesenteric circulation.
In addition, no studies were performed to assess the degree
or presence of capillary blockage or histologic tissue damage
as a result of the contrast agent injection. Because of the
unresolved issue of toxicity and the lack of information on
the effect of microbubble injections on other organs or vas-
cular systems, we do not believe that this technique is ap-
propriate for use in human patients at this time.
Systolic wall thickening versus extent of infarction. In
this experiment, analysis of systolic wall thickening cor-
related poorly with the amount of infarcted myocardium.
There are several explanations for this. First, determination
of systolic thickening requires accurate identification of two
sets of endocardial and epicardiac contours, and then ac-
curate alignment of systolic and diastolic contours to correct
for cardiac motion. Precise alignment of these contours is
difficult in an open chest model because of exaggerated
cardiac motion. This will result in error as the systolic-
diastolic comparison may not be made at identical points
along the long axis of the left ventncle. In addition, systolic
thinning will be seen in regions of subendocardial infarction
(6). In our study, myocardial infarction was quantified in
all areas of the myocardium, whereas wall thickening was
assessed only for the full transmural thickness. This will
introduce error because regions of myocardium with only
subendocardial infarction may show abnormal wall motion
but, at least partially, will be described as normal by nitro-
blue tetrazolium staining and contrast echocardiography.
Furthermore, the infarction involved a papillary muscle in
six dogs. As the papillary muscles were included in infarct
size determination for both the contrast echocardiographic
studies and the nitro-blue tetrazolium studies but not for
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Figure 5. Cornpanson of fraction of rnyocardium Infarcted as
determined with contrast-enhancedechocardiography(ECHO,CEl
and nitro-blue tetrazolium staining(NBTl. N = number of studies:
P = probability: R = correlation coeffi cient.
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Sources of er ror. There are two potential sources of
systematic error when contrast echocardiography is used to
determine infarct size. First, the ultrasound contrast effect
is a marker for myocardial perfusion and not necessarily
infarction (8). Areas of reduced perfusion adjacent to the
infarct will be detected as abnormal with this technique.
This would cause an overestimation of infarct size by con-
trast echocardiography. The magnitude of this overesti-
mation has not been determined for this technique. Second,
echocardiographic beam width and resolution have not been
investigated for contrast-enhanced targets . The increased
reflectance from the contrast-enhanced myocardium would
be expected to increase effective beam width and reduce
resolution. This should lead to an overestimation of the
amount of contrast-enhanced myocardium, and thus an
underestimation of infarct size. The role of these factors
clearly needs further investigation and may explain our in-
ability to determine precisely infarct size .
Advantages of the method. Contrast-enhanced echo-
cardiography has several potential advantages over other
imaging techniques that are currently employed in evalu-
ating myocardial ischemia and infarction. Because it is a
tomographic technique, the resolution of echocardiography
should be higher than that of radiographic or radionuclide
techniques when used to evaluate myocardial structure and
function. Furthermore, contrast-enhanced echocardiography
is unique in that it allows a direct and simultaneous as-
sessment of both myocardial perfusion status and the func-
tional status of the myocardium.
Figure 4. Two-dimensional echocardiogram before (A) and after
(B) contrast enhancement from a dog with a leftanterior descend-
ing coronary artery occlusion. After injection of the contrast ma-
terial into the aortic root (panel B), only the areaof myocardium
from approximately 4 o'clock to 8 o'clock increased in image
intensity (arrows). This corresponds to the perfusion distribution
of the patent circumflex coronary artery. The fractionof Infarcted
myocardium by contrast echocardiography was 0.48; by nitro-blue
tetrazolium. 0.55; and by wall thickening. 0.34.
wall thickening analysis, an obvious source of error was
introduced.
Accuracy of contrast -enhanced echoca rdiography. In
this study, the correlation between myocardial infarct size
by contrast echocardiography and nitro-blue tetrazolium
staining was excellent. Reproducibility of the infarct size
determination was excellent for both intra- (r = 0.93) and
interobserver (r = 0.89) comparisons. The line comparing
the contrast echocardiographic and nitro-blue tetrazolium
extent of infarction suggests an overestimation at the lower
range and an underestimation of infarct extent at the upper
range of infarct sizes. We have no solid explanation for this
phenomenon, but believe that with further experience this
relation may become more consistent.
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Clinical applications. If agents can be developed for
myocardial perfusion studies in human subjects, contrast-
enhanced echocardiography should have widespread appli-
cation in evaluating patients with coronary artery disease.
Myocardial infarct sizing may be feasible with this technique
if three-dimensional reconstruction of the left ventricular
myocardium can be accomplished. Furthermore, as the ul-
trasound contrast effect parallels perfusion, and not nec-
essarily infarction, contrast-enhanced echocardiography may
accurately define the area of myocardium at risk from oc-
clusive coronary artery lesions. Other potential clinical uses
would include assessment of coronary artery bypass graft
patency and flow distribution, and assessment of the results
of interventions such as streptokinase infusion or coronary
angioplasty.
In summary, we have demonstrated that a mixture of
hydrogen peroxide and blood injected into the aortic root
of dogs provides an excellent myocardial ultrasound contrast
effect. We have shown that the location of this ultrasound
contrast effect parallels normal perfusion and that the es-
timate of myocardial infarct size obtained with this tech-
nique is accurate when compared with results of macro-
scopic histologic staining.
We gratefully acknowledge the technical assistance of Cathy Mitchell and
the secretarial support of Cheryl Childress.
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